Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,918 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study.
Pasic I, Moya TA, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J. Pasic I, et al. Among authors: lam w. Transplant Cell Ther. 2024 Apr 20:S2666-6367(24)00367-1. doi: 10.1016/j.jtct.2024.04.014. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38648898
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Alanazi W, Chen S, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law AD, Al-Shaibani Z, Mattsson J, Michelis FV. Alanazi W, et al. Among authors: lam w. Acta Haematol. 2021;144(1):66-73. doi: 10.1159/000507536. Epub 2020 May 19. Acta Haematol. 2021. PMID: 32428903 Free article.
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation.
Salas MQ, Atenafu EG, Bascom O, Wilson L, Lam W, Law AD, Pasic I, Kim DDH, Michelis FV, Al-Shaibani Z, Gerbitz A, Viswabandya A, Lipton JH, Mattsson J, Alibhai SMH, Kumar R. Salas MQ, et al. Among authors: lam w. Bone Marrow Transplant. 2021 Jan;56(1):60-69. doi: 10.1038/s41409-020-0979-1. Epub 2020 Jun 30. Bone Marrow Transplant. 2021. PMID: 32606454
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
Vasudevan Nampoothiri R, Chen S, Pasic I, Al-Shaibani Z, Lam W, Michelis FV, Kim DDH, Viswabandya A, Gerbitz A, Lipton JH, Kumar R, Mattsson J, Law AD. Vasudevan Nampoothiri R, et al. Among authors: lam w. Hematol Oncol Stem Cell Ther. 2021 Jun;14(2):134-140. doi: 10.1016/j.hemonc.2020.09.001. Epub 2020 Oct 8. Hematol Oncol Stem Cell Ther. 2021. PMID: 33049225 Free article.
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Smith E, Huang J, Viswabandya A, Maze D, Malik S, Cheung V, Siddiq N, Claudio J, Arruda A, Kennedy J, Bankar A, Law AD, Lam W, Michelis FV, Kim D, Lipton J, Kumar R, Mattsson J, McNamara C, Sibai H, Xu W, Gupta V. Smith E, et al. Among authors: lam w. Transplant Cell Ther. 2021 Jul;27(7):600.e1-600.e8. doi: 10.1016/j.jtct.2021.03.027. Epub 2021 Mar 30. Transplant Cell Ther. 2021. PMID: 33798769 Free article.
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.
Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Dong Hwan Kim D, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Salas MQ, et al. Among authors: lam w. Transplant Cell Ther. 2021 May;27(5):428.e1-428.e9. doi: 10.1016/j.jtct.2021.02.007. Epub 2021 Feb 13. Transplant Cell Ther. 2021. PMID: 33965185 Free article.
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation.
Nampoothiri RV, Ho L, McEwan C, Pasic I, Lam W, Law AD, Michelis FV, Thyagu S, Kim DDH, Gerbitz A, Viswabandya A, Lipton JH, Mattsson J, Kumar R. Nampoothiri RV, et al. Among authors: lam w. Bone Marrow Transplant. 2021 Oct;56(10):2471-2476. doi: 10.1038/s41409-021-01362-2. Epub 2021 Jun 9. Bone Marrow Transplant. 2021. PMID: 34108675
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.
Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J. Carreira AS, et al. Among authors: lam w. Transplant Cell Ther. 2022 Jan;28(1):50.e1-50.e8. doi: 10.1016/j.jtct.2021.10.008. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656808 Free article.
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM, Nampoothiri RV, Chen C, Pasic I, Al-Shaibani Z, Lam W, Law AD, Michelis FV, Kim DDH, Gerbitz A, Lipton J, Kumar R, Mattsson J, Viswabandya A. Linn SM, et al. Among authors: lam w. Hematol Oncol Stem Cell Ther. 2023 Apr 4;16(3):230-237. doi: 10.1016/j.hemonc.2021.09.008. Hematol Oncol Stem Cell Ther. 2023. PMID: 34856195
2,918 results